Participation in Dubai Derma 2025
2025-04-17
본문

Formally entering the Middle East at the region’s largest dermatology congress
Dubai, UAE — 14–16 April 2025 — Genèse Labs took part in Dubai Derma 2025 at the Dubai World Trade Centre, formally entering the Middle East and North Africa (MENA) aesthetic market.
• Participation in the largest scientific dermatology gathering in the Middle East, North Africa and the Indian Subcontinent
• An exhibition featuring more than 400 companies from around the world
• Facial and body HA and biostimulator portfolio presented, including the newly launched Réluma
• Groundwork laid for distribution partnerships across the MENA region
A Gateway to the MENA Market
Dubai Derma is the region’s largest scientific and commercial event, drawing tens of thousands of dermatologists, aesthetic physicians and industry professionals each year. As a distribution hub linking the Gulf with North Africa and South Asia, Dubai offers access to an extensive regional network through a single event.
A Market That Values Premium Quality and Trust
The Middle East market has strong demand for premium products and places high value on provenance and certification history. Developed in France and backed by CE certification and KFDA approval, the Genèse Labs portfolio met those expectations — with Proluma™ PDLLA and PLLA and the newly launched Réluma drawing particular interest from regional practitioners.
The Starting Point for a Lasting Regional Presence
Dubai Derma 2025 marked the beginning of Genèse Labs’ activity in the Middle East. The relationships started here have led to continued congress participation and expanding distribution partnerships in the region. The Middle East now stands alongside Europe, Asia and Latin America as a priority market for the company.
“Practitioners in the Middle East look closely at where a product comes from and what stands behind it. That is exactly why French-developed, internationally certified products hold an advantage here.” — Genèse Labs, Company statement
About Genèse Labs
Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across body contouring, collagen biostimulation, hyaluronic acid fillers and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including the RG Body Filler line, Proluma™ (PDLLA, PLLA and RH Collagen), Réluma, Citrus Bottle™, Exoluma™ (Human, Plant and Exo-PDRN) and Exo-Mask — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.
Contact
For distributor inquiries, collaborations, or product information, please contact:




